GW&K Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-104,337
Closed -$9.31M 302
2018
Q1
$9.31M Sell
104,337
-5,536
-5% -$531K 0.16% 189
2017
Q4
$11.5M Sell
109,873
-15,746
-13% -$1.78M 0.2% 178
2017
Q3
$18.3M Sell
125,619
-1,677
-1% -$228K 0.31% 137
2017
Q2
$16.5M Buy
127,296
+13,707
+12% +$1.68M 0.29% 143
2017
Q1
$14.1M Sell
113,589
-4,908
-4% -$587K 0.27% 138
2016
Q4
$13.7M Sell
118,497
-3,126
-3% -$348K 0.27% 140
2016
Q3
$12.7M Buy
121,623
+9,849
+9% +$1.07M 0.24% 151
2016
Q2
$11M Sell
111,774
-2,617
-2% -$271K 0.23% 145
2016
Q1
$11.4M Buy
114,391
+30,608
+37% +$3.15M 0.25% 134
2015
Q4
$10M Buy
83,783
+2,745
+3% +$318K 0.24% 137
2015
Q3
$8.77M Buy
81,038
+22,594
+39% +$2.8M 0.21% 144
2015
Q2
$6.76M Buy
+58,444
New +$6.68M 0.15% 157

Other funds holding CELG

GW&K Investment Management's CELG Position: Q2 2018 in Review

GW&K Investment Management sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 104,337 shares — an estimated $9.31M sold.

GW&K Investment Management first reported a position in CELG in Q2 2015 and held it in 12 quarters. The position peaked at $18.3M in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • GW&K Investment Management reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • GW&K Investment Management sold 104,337 Celgene Corp shares in Q2 2018, an estimated $9.31M.
  • GW&K Investment Management first reported a position in Celgene Corp in Q2 2015 and held it in 12 quarters.
  • GW&K Investment Management's Celgene Corp position peaked at $18.3M in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on GW&K Investment Management's 13F filing for Q2 2018, filed 7 Aug 2018.